UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pore-lining sudoite in Rotliegend sandstones from the eastern part of the Southern Permian Basin

Clay minerals, 2014-12, Vol.49 (5), p.635-655

Biernacka, J .

2014

Volltextzugriff (PDF)

Glycine and a Glycine Dehydrogenase ( ) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics-Informed Pharmacogenomics

Clinical pharmacology and therapeutics, 2011-01, Vol.89 (1), p.97-104

2011

Volltextzugriff (PDF)

Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2

Molecular psychiatry, 2014-09, Vol.19 (9), p.1010-1016

2014

Volltextzugriff (PDF)

SLC6A4 variation and citalopram response

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2009-04, Vol.150B (3), p.341-351

2009

Volltextzugriff (PDF)

TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics

Molecular psychiatry, 2016-12, Vol.21 (12), p.1717-1725

2016

Volltextzugriff (PDF)

Clinical Correlates of Cardiac Conduction in Bipolar Disorder

European psychiatry, 2022-06, Vol.65 (S1), p.S402-S402

2022

Volltextzugriff (PDF)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

Translational psychiatry, 2015-04, Vol.5 (4), p.e553-e553

2015

Volltextzugriff (PDF)

Evening chronotype, disordered eating behavior, and poor dietary habits in bipolar disorder

Acta psychiatrica Scandinavica, 2020-07, Vol.142 (1), p.58-65

2020

Volltextzugriff (PDF)

Using a pharmacogenomic algorithm to guide the treatment of depression

Translational psychiatry, 2012-10, Vol.2 (10), p.e172-e172

2012

Volltextzugriff (PDF)

Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics

The pharmacogenomics journal, 2013-10, Vol.13 (5), p.456-463

2013

Volltextzugriff (PDF)

Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders

Translational psychiatry, 2015-12, Vol.5 (12), p.e689-e689

2015

Volltextzugriff (PDF)

Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate

Translational psychiatry, 2014-10, Vol.4 (10), p.e462-e453

2014

Volltextzugriff (PDF)

New insights into the pharmacogenomics of antidepressant response from the GENDEP and STARD studies: rare variant analysis and high-density imputation

The pharmacogenomics journal, 2018-05, Vol.18 (3), p.413-421

2018

Volltextzugriff (PDF)

Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability

Journal of biological physics, 2014-09, Vol.40 (4), p.335-345

2014

Volltextzugriff (PDF)

Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects

Translational psychiatry, 2015-08, Vol.5 (8), p.e621-e621

2015

Volltextzugriff (PDF)

Improving lithium dose prediction using population pharmacokinetics and pharmacogenomics: a cohort genome-wide association study in Sweden

The Lancet. Psychiatry, 2022-06, Vol.9 (6), p.447-457

2022

Volltextzugriff (PDF)

Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response

The pharmacogenomics journal, 2012-02, Vol.12 (1), p.78-85

2012

Volltextzugriff (PDF)

Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbidities

Translational psychiatry, 2016-08, Vol.6 (8), p.e870-e870

2016

Volltextzugriff (PDF)

Association of the serotonin transporter-linked polymorphic region genotype with lower bone mineral density

Translational psychiatry, 2017-08, Vol.7 (8), p.e1213-e1213

2017

Volltextzugriff (PDF)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

Translational psychiatry, 2016-11, Vol.6 (11), p.e937-e937

2016

Volltextzugriff (PDF)

CLINICAL AND GENETIC MARKERS ASSOCIATED WITH THE LENGTH OF SOBRIETY IN HUMAN ALCOHOLICS TREATED WITH ACAMPROSATE

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2015, Vol.39, p.295A

2015

Volltextzugriff (PDF)

Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts

PloS one, 2018-09, Vol.13 (9), p.e0203896

2018

Volltextzugriff (PDF)

Methylation of Brain Derived Neurotrophic Factor (BDNF) Val66Met CpG site is associated with early onset bipolar disorder

Journal of affective disorders, 2020-04, Vol.267, p.96-102

2020

Volltextzugriff (PDF)

O-25 - Variations in PDYN sequence are associated with negative craving in alcohol dependent subjects

European psychiatry, 2012-01, Vol.27, p.1

2012

Volltextzugriff (PDF)

Gene set analysis of SNP data: benefits, challenges, and future directions

European journal of human genetics : EJHG, 2011-08, Vol.19 (8), p.837-843

2011

Volltextzugriff (PDF)

1 – 25 von 378

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(352)
Mit Volltextzugriff
(324)

Publikationsform

Artikel
(368)
Tagungsberichte
(10)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pore-lining sudoite in Rotliegend sandstones from the eastern part of the Southern Permian Basin

Glycine and a Glycine Dehydrogenase ( ) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics-Informed Pharmacogenomics

Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2

SLC6A4 variation and citalopram response

TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics

Clinical Correlates of Cardiac Conduction in Bipolar Disorder

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

Evening chronotype, disordered eating behavior, and poor dietary habits in bipolar disorder

Using a pharmacogenomic algorithm to guide the treatment of depression

Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics

Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders

Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate

New insights into the pharmacogenomics of antidepressant response from the GENDEP and STARD studies: rare variant analysis and high-density imputation

Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability

Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects

Improving lithium dose prediction using population pharmacokinetics and pharmacogenomics: a cohort genome-wide association study in Sweden

Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response

Leveraging electronic health records to study pleiotropic effects on bipolar disorder and medical comorbidities

Association of the serotonin transporter-linked polymorphic region genotype with lower bone mineral density

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

CLINICAL AND GENETIC MARKERS ASSOCIATED WITH THE LENGTH OF SOBRIETY IN HUMAN ALCOHOLICS TREATED WITH ACAMPROSATE

Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts

Methylation of Brain Derived Neurotrophic Factor (BDNF) Val66Met CpG site is associated with early onset bipolar disorder

O-25 - Variations in PDYN sequence are associated with negative craving in alcohol dependent subjects

Gene set analysis of SNP data: benefits, challenges, and future directions

Suchergebnisse filtern